Second Quarter Organic Sales Growth
Reported a 0.6% organic sales growth in the second quarter despite an uncertain macro environment.
Adjusted EPS and EBITDA Margin Expansion
Adjusted EPS grew 5% to $0.80, slightly ahead of guidance, with adjusted EBITDA margins expanding by 30 basis points to 17.2%.
Strong Performance in Defense and Health Care
Defense and health care sectors showed strong demand, with health care growing double digits.
Debt Reduction Achievements
Paid down $50 million of debt during the quarter, with plans to reduce total debt by $100 million to $200 million by year-end.
Patent Filings and Innovation
Patent filings increased by 50% in 2024 versus 2023, with expectations to exceed year-over-year filings again in 2025.